avidbio.
0-49764).

fever infectious

Pathogens to be screened in this collaboration belong to a class of
viruses known as "enveloped viruses," which derive their outermost coating
from their host cell membrane during viral replication. NIAID conducts and supports
basic and applied research to prevent , diagnose and treat infectious diseases
such as HIV/AIDS and other sexually transmitted infections , influenza,
tuberculosis, SARS, malaria and illness from potential agents of bioterrorism. Our oncology programs are primarily focused on the areas of
anti-phospholipid technology, anti-angiogenesis and vascular targeting.net.sinofresh. The Company's actual results could differ materially from
such forward-looking statements.

infectious fevers

Our business could be affected by all
of the foregoing and a number of other factors, including the risk factors
listed from time to time in the Company's SEC reports including, but not
limited to, the annual report on Form 10-K for the year ended April 30, 2004,
and the quarterly report on Form 10-Q for the quarter ended January 31, 2005. Rachel Martin
Frank Hawkins and Ken AuYeung Edelman
(800) 987-8256 (323) 202-1031/(323) 893-9047
Rachel.Net, SinoFresh continues its
effort to increase the company's exposure and distribute information
to the investment community. This is a great platform for our company
to reach SinoFresh's shareholders as well as potential investors while
delivering our story in a way that is both personal and efficient,"
stated Charles Fust .Net is an information and media company that
provides a Web-based forum for public and private issuers to
communicate corporate audio and video news content to the business,
financial and investing community through its Web site, located at
http://www.

* SinoFresh(TM) is a trademark of SinoFresh HealthCare, Inc.

yeast bacterial

Pichinde virus is
on the U. government's biodefense Category A watch list. The MacReport. The Company undertakes no obligation
to update any forward-looking statement or statements to reflect new
events or circumstances or future developments.

yeast enterocolitica

Virus types to be
screened as part of the collaboration potentially include herpes viruses,
respiratory viruses, pox viruses, Hepatitis B and C, Papillomavirus and
viruses of biodefense concern including Pichinde, Yellow Fever, West Nile and
Dengue. Since viruses lack the
means to maintain structural organization of the envelope , amino-phospholipids
such as phosphatidylserine (PS) and phosphatidylethanolamine (PE) become
exposed on the surface of these viruses, making them potential therapeutic
targets.

Business Editors /Health Editors

ENGLEWOOD, Fla.

About The MacReport. The Company holds many patents and patent
applications on its innovative pharmaceutical technology and relies
upon a distinguished panel of medical experts and a management team
experienced in the bio-pharmaceutical arena.com

Except for the historical information contained herein, this press
release contains forward-looking statements made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act of
1995.

y fever

It is based on
the finding that aminophospholipids, which are basic components of the inner
surface of the cell membrane, become exposed as antigenic targets in certain
disease states. It is important to note that the Company's
actual results could differ materially from those in any such forward-looking
statements.

yellow fungal

, Peregrine
Pharmaceuticals Inc.

About Anti -Phospholipid Therapy in the Treatment of Viral Diseases
Anti-Phospholipid Therapy is Peregrine Pharmaceuticals' novel approach to
treating cancer, viral infections and certain ocular diseases . Avid is engaged
in providing contract manufacturing services and development of biologics for
biopharmaceutical and biotechnology companies, including Peregrine. (OTC BB: SFSH), marketer of the only over-the-counter
nasal spray that kills bacteria and fungi, announced today that CEO
Charles Fust and SinoFresh are featured on the MacReport. Any forward-looking statements speak only as of the date on
which such statements are made and involve risks and uncertainties
detailed in the Company's filings with the Securities and Exchange
Commission, including risks summarized in the Company's Annual Report
on Form 10-KSB for its fiscal year ended December 31, 2003 (file No.

conditions y

, (http://www.com

The Company's lead product, SinoFresh(TM) Nasal + Sinus Care, is
the first over-the -counter antiseptic nasal spray that kills bacteria
and fungi in the mouth and nose.

yellow yersinia

disclaims any obligation, and does not
undertake, to update or revise any forward-looking statements in this press
release.

About SinoFresh HealthCare, Inc. More information is available at
www.

health diseases

National Institute of Allergies and Infectious Diseases to Test Tarvacin(TM) for Antiviral Potential

About Peregrine Pharmaceuticals
Peregrine Pharmaceuticals, Inc.
Peregrine Pharmaceuticals also has in-house expertise to develop and
manufacture antibodies and recombinant proteins through its wholly-owned
subsidiary, Avid Bioservices, Inc.

SinoFresh HealthCare, Inc.

fevers enterocolitica

NIAID also supports research on transplantation and immune-related illnesses,
including autoimmune disorders , asthma and allergies. is a biopharmaceutical company with a
broad portfolio of products under development directed towards the treatment
of cancer, viruses and other diseases.Martin@edelman.

yersinia viral

"We are very pleased to be able to work with the NIAID to further explore
the anti-viral potential of Tarvacin (TM) and the rest of our Anti-Phospholipid
Therapy agents," said Steven King, president and CEO of Peregrine
Pharmaceuticals. Results from these studies
are being presented at the annual meeting of the American Association of
Immunologists taking place this week in San Diego, California.

SinoFresh Featured on MacReport.Net

is a developer and marketer of
innovative therapies to treat inflammatory and infectious diseases of
the upper respiratory system.

yeast fungal

68 million grant from the
NIAID, scientists at the University of Texas Southwestern Medical Center at
Dallas determined that Tarvacin(TM) binds to virally infected cells and viral
particles including Pichinde virus, which causes a fatal viral hemorrhagic
fever and is used as an established model for Lassa fever.S. Enveloped viruses
account for many of the most concerning viral health risks including HIV,
Hepatitis B and C, cytomegalovirus , hemorrhagic fever, SARS and various types
of influenza including Avian influenza. Peregrine Pharmaceuticals , together with its collaborators, has
developed a series of monoclonal antibodies directed against
aminophospholipids to take advantage of this property. Department of Health and Human Services. Peregrine's viral therapy approach is
based on the fact that enveloped viruses and virally infected cells have
phospholipids exposed on their surface and thus can be targeted using our APT
agents .
Peregrine Pharmaceuticals, Inc.----SinoFresh
HealthCare, Inc.
"Through our presence on the MacReport.macreport.

viral conditions

"The data that will be generated from this collaboration
will be very helpful in guiding development of our Tarvacin(TM) anti-viral
clinical program.
Copies of Peregrine Pharmaceuticals press releases, SEC filings, current
price quotes and other valuable information for investors may be found at
http://www. Factors that could cause actual results to differ materially
include, but are not limited to, uncertainties associated with completing
pre-clinical and clinical trials for our technologies; the early stage of
product development; the significant costs to develop our products as all of
our products are currently in development, pre-clinical studies or clinical
trials; our ability to obtain additional financing to support our operations
and the development of our products; our ability to obtain regulatory approval
for our technologies; the timing of regulatory filings and the potential
success in gaining regulatory approval and complying with governmental
regulations applicable to our business.

conditions enterocolitica

The researchers
further determined that Tarvacin(TM) also significantly protected animals
challenged with a lethal dose of Pichinde virus.com).Net, Inc .

The MacReport.Net also plans to provide
creative and production services to develop visual events ranging from
live coverage of merger announcements to public relations campaigns to
new product introductions. The Company is researching
broad-spectrum antiseptic approaches to reducing viral, bacterial, and
fungal organisms that are suspected to cause pathogenesis of the
mouth, nose, and throat. SinoFresh(TM) Nasal +
Sinus Care is available nationwide in Wal-Mart, Walgreens , Rite Aid,
CVS, Sav-on drugs, Osco Drug and other drug, grocery and mass
merchandise retailers .

y fungal

Peregrine Pharmaceutical's Anti-Phospholipid Therapy to Be Screened Against
Broad Spectrum of Viruses That Threaten Worldwide Health and Global Security

TUSTIN, Calif. (Nasdaq: PPHM) and the National Institute of Allergy and
Infectious Disease (NIAID) have agreed to a collaboration in which NIAID's
testing laboratories will screen Peregrine's Anti-Phospholipid Therapy agents,
including Tarvacin(TM), for activity against a broad spectrum of enveloped
viral pathogens of health and bioterrorism concern.

About the National Institute of Allergies and Infectious Diseases (NIAID)
NIAID is a part of the National Institutes of Health, an agency of the
U.S.

viral fever

"
During the first year of an ongoing 3-year, $1.
A large number of viruses that impact global health and security possess
an "envelope" derived from their host cell membrane.peregrineinc.com

Statements in this press release which are not purely historical,
including statements regarding Peregrine Pharmaceutical 's intentions, hopes,
beliefs, expectations, projections, plans or predictions of the future, are
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995.

Investor Inquiries Media Inquiries
Hawk Associates , Inc.Net, a
leading provider of online business and financial information. The Company is also researching how
antiseptic cleansing may aid in alleviating sinus distress, a problem
that may affect 37 million Americans annually.